Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen (Q39981110)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

electroporation

1 reference

based on heuristic

inferred from title

David Hallengärd

2

object named as

David Hallengärd

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Lindvi Gudmundsdotter

3

object named as

Lindvi Gudmundsdotter

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

6

object named as

Britta Wahren

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Andreas Bråve

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Richard Stout

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Richard Walters

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Kristian Hallermalm

7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

language of work or name

0 references

publication date

3 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

3692-3696

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Electropermeabilization of skeletal muscle enhances gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Pre-clinical evaluation of a CEA DNA prime/protein boost vaccination strategy against colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Intracellular targeting of CEA results in Th1-type antibody responses following intradermal genetic vaccination by a needle-free jet injection device.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Hepatitis A vaccine administration: comparison between jet-injector and needle injection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: study of immunological memory and long-term toxicology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Vaccination of infants with a four-dose and a three-dose vaccination schedule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Extended immunization intervals enhance the immunogenicity and protective efficacy of plasmid DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Jump-starting the immune system: prime-boosting comes of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Combination of recombinant xenogeneic endoglin DNA and protein vaccination enhances anti-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Humoral immune response after genetic immunization is consistently improved by electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.013

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.04.013

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39981110&oldid=1961439779"